Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa

Vaccine

Volumn 28, Issue 50, 2010, Pages 8026-8032

  Francis, Shelley A ^a   Nelson, Jennifer ^b   Liverpool, Joan ^c   Soogun, Soji ^d   Mofammere, Nokuthula ^d   Thorpe, Roland J ^e  

^a OHIO STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c Deskan Institute   (United States)

^d Consulting Rooms: No 97 12Avenue ^*  (South Africa)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cervical cancer prevention; HPV; South Africa

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; CANCER RISK; FEMALE; HEALTH CARE ACCESS; HUMAN; MATERNAL CARE; MATERNAL WELFARE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SOUTH AFRICA; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; DEVELOPING COUNTRIES; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78650252108     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.090     Document Type: Article

References (25)

1. World Health Organization. Preparing for the introduction of HPV vaccines: policy and programme guidance for countries. World Health Press, Geneva, Switzerland, 2006, p. 1-22.
2. Pillay A.L. Rural and urban South Africa women's awareness of cancers of the breast and cervix. Ethnicity and Health 2002, 7(2):103-114.
3. Moodley J., Kawonga M., Bradley J., Hoffman M. Challenges in implementing a cervical cancer screening program in South Africa. Cancer Detection and Prevention 2006, 30:361-368.
4. Cancer rates in South Africa. Available at Accessed February 1, 2007. http://sahealthinfo.org/.
5. National Department of Health National guidelines for cervical cancer screening programme Pretoria, South Africa 2000.
6. McFarland D.M. Cervical cancer and Pap smear screening in Botswana: knowledge and perceptions. International Nursing Review 2003, 50:167-175.
7. Harries J., Moodley J., Barone M.A., Mall S., Sinanovic E. Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine 2009, 27:38-44.
8. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer Human Papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. Journal of Adolescent Health 2005, 37(6):502-510.
9. Marlow LAV, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 25(11):1945-1952.
10. Dinh T.A., Rosenthal S.L., Doan E.D., Trang T., Pham V.H., Tran B.D., et al. Attitudes of mothers in Da Nang, Vietnam toward a Human Papillomavirus vaccine. Journal of Adolescent Health 2006, 10:1016.
11. Zimet G.D., Mays R.M., Sturm L.A., Ravert A.A., Perkins S.M., Juliar B.E. Parental attitudes about sexually transmitted infection vaccination for the their adolescent children. Archives of Pediatric Adolescent Medicine 2005, 159:132-137.
12. Center for Disease Control and Prevention. HPV-STD Information. Available at Accessed on June 14, 2007. http://www.cdc.gov/std/hpv/.
13. Nelson, J.A. Francis, S.A., Liverpool, J., Shogun, S., Frank, S.H., Mofammere, N. " Traditional Healers in a Non-Traditional Role; A focus group analysis of the Sangomas' view of cervical cancer knowledge, attitudes and the HPV vaccine in Johannesburg, South Africa." Sexual & Reproductive Health Care. in press.
14. Gerhardt C.A., Pong K., Kollar L.M., Hillard P.J., Rosenthal S.L. Adolescents' knowledge of Human Papillomavirus and cervical dysplasia. Journal of Pediatric and Adolescent Gynecology 2000, 13:15-20.
15. Koutsky L. Epidemiology of genital Human Papillomavirus infection. American Journal of Medicine 1997, 102(5A):3-8.
16. Marteau T.M., Hankins M., Collins B. Perceptions of risk of cervical cancer and attitudes towards cervical screening: a comparison of smokers and non-smokers. Family Practice 2002, 19(1):18-22.
17. Dempsey A.F., Zimet G.D., Davis R.L., Koutsky L. Factors that are associated with parental acceptance of Human Papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006, 117:1486-1493.
18. Philips Z., Johnson S., Avis M., Whynes D.K. Human Papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Education Research 2003, 18(3):318-328.
19. Pitts M., Clarke T. Human Papillomavirus infections and risks of cervical cancer: what do women know?. Health Education Research 2002, 17(6):706-714.
20. Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahé C., et al. Cost-effectiveness of cervical cancer screening in five developing countries. The New England Journal of Medicine 2005, 353:2158-2168.
21. Agosti, Goldie Introducing HPV vaccine in developing countries-key challenges and issues. The New England Journal of Medicine 2007, 356:1908-1910.
22. Goldie S.J., Kim J.J., Kobus K., Goldhaber-Fiebert J.D., Salomon J., O'shea M.K., et al. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 2007, 25:6257-6270.
23. The World Bank. Gross national income per capita 2009, Atlas method and PPP. World Development Indicators database. World Bank, revised 9 July 2010.
24. Fisher K., Bass E. Stop cervical cancer: accelerating global access to HPV vaccines, London; 2006.
25. Vijayaraghavan A., et al. Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa. Gynecology Oncology 2008, 10.1016/j.ygyno.2008.08.030.